These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1638777)
21. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study]. Romics L; Karádi I; Csanády M; Gógl A; Jánosi A; Ofner P; Tarján J; Varga L; Wórum F; Zeltner G Orv Hetil; 1994 Oct; 135(40):2187-91. PubMed ID: 7970631 [TBL] [Abstract][Full Text] [Related]
22. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus]. van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172 [TBL] [Abstract][Full Text] [Related]
23. Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia. Denke MA Arch Intern Med; 1994 Sep; 154(17):1977-82. PubMed ID: 8074602 [TBL] [Abstract][Full Text] [Related]
24. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits. Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875 [TBL] [Abstract][Full Text] [Related]
25. [Lovastatin. A new drug for the treatment of hypercholesterolemia]. Abouganem D; Núñez P Rev Med Panama; 1990 Sep; 15(3):184-96. PubMed ID: 2284448 [TBL] [Abstract][Full Text] [Related]
26. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Agrawal AR; Tandon M; Sharma PL Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545 [TBL] [Abstract][Full Text] [Related]
27. Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria. Golper TA; Illingworth DR; Morris CD; Bennett WM Am J Kidney Dis; 1989 Apr; 13(4):312-20. PubMed ID: 2650539 [TBL] [Abstract][Full Text] [Related]
28. The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome. Kasiske BL; Velosa JA; Halstenson CE; La Belle P; Langendörfer A; Keane WF Am J Kidney Dis; 1990 Jan; 15(1):8-15. PubMed ID: 2294737 [TBL] [Abstract][Full Text] [Related]
29. Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism. Vega GL; Grundy SM Kidney Int; 1988 Jun; 33(6):1160-8. PubMed ID: 3165483 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus. Goldberg R; La Belle P; Zupkis R; Ronca P Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032 [TBL] [Abstract][Full Text] [Related]
31. C-reactive protein level following treatment and withdrawal of lovastatin in diabetic nephropathy. Rashtchizadeh N; Argani H; Ghorbanihaghjo A; Nezami N; Safa J; Montazer-Saheb S Iran J Kidney Dis; 2009 Apr; 3(2):93-8. PubMed ID: 19395785 [TBL] [Abstract][Full Text] [Related]
32. Lovastatin in the treatment of hypercholesterolemia in CAPD. Krane NK; Stock G; Caballero M; Starks E Adv Perit Dial; 1992; 8():362-4. PubMed ID: 1361823 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease. Anguita M; Alonso-Pulpón L; Arizón JM; Cavero MA; Vallés F; Segovia J; Pérez-Jiménez F; Crespo M; Concha M Am J Cardiol; 1994 Oct; 74(8):776-9. PubMed ID: 7942548 [TBL] [Abstract][Full Text] [Related]